Europe COVID-19 In-Vitro Diagnostics Market was valued at USD 10 Billion in 2022 and is projected to reach USD 16 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
The COVID-19 In-Vitro Diagnostics Market has witnessed substantial growth across Europe, driven by the urgent need for accurate, rapid testing during the pandemic. As the world continues to battle the effects of COVID-19, the demand for in-vitro diagnostic (IVD) tools has surged to unprecedented levels. The primary industries relying on these tools are healthcare, pharmaceuticals, and biotechnology, all of which require innovative and highly effective diagnostic solutions to manage the crisis.
As countries in Europe grapple with COVID-19's unpredictable nature, the healthcare industry has seen a massive spike in demand for diagnostic tools, ranging from PCR testing kits to rapid antigen tests. These tools are crucial in detecting the virus and preventing its spread. The market’s rapid expansion reflects a critical shift in healthcare approaches, with a focus on more efficient and scalable diagnostic solutions that can be deployed in varied settings such as hospitals, clinics, and even at-home testing kits. European healthcare facilities have increasingly relied on in-vitro diagnostics, thanks to their precision and speed in delivering results.
Moreover, the pharmaceutical industry has become a key player in the market, developing diagnostic tests that not only detect the virus but also help track its mutations. This is especially crucial as new variants of the virus emerge, requiring constant innovation in the IVD market. Biotechnology companies are also contributing to the development of advanced diagnostic methods that push the boundaries of traditional testing technologies, ensuring Europe remains at the forefront of the global healthcare response to the pandemic.
With a growing need for diverse diagnostic types, the demand for customized solutions has also risen. In the European market, industries require tests that are not only accurate but also cost-effective and scalable. Furthermore, integration with data management platforms and real-time result reporting systems is becoming increasingly necessary for efficient disease management and containment. As testing volumes increase and technology evolves, Europe’s COVID-19 In-Vitro Diagnostics Market continues to expand, offering new opportunities and challenges for healthcare providers and diagnostic solution developers alike.
Get an In-Depth Research Analysis of the Europe COVID-19 In-Vitro Diagnostics Market Size And Forecast [2025-2032]
Â
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe COVID-19 In-Vitro Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe COVID-19 In-Vitro Diagnostics Market
PCR Tests
Antigen Tests
Antibody Tests
Nucleic Acid Tests
Consumables
Instruments
Software
Hospitals
Diagnostic Laboratories
Home Care Settings
Blood Banks
Blood Samples
Respiratory Samples
Saliva
Other Body Fluids
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
LAMP (Loop-mediated Isothermal Amplification)
Microarray Technology
Next-Generation Sequencing (NGS)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ COVID-19 In-Vitro Diagnostics Market Research Analysis
1. Introduction of the Europe COVID-19 In-Vitro Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe COVID-19 In-Vitro Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe COVID-19 In-Vitro Diagnostics Market, By Type
6. Europe COVID-19 In-Vitro Diagnostics Market, By Application
7. Europe COVID-19 In-Vitro Diagnostics Market, By Geography
Europe
Germany
UK
France
8. Europe COVID-19 In-Vitro Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/